10th Mar 2026 15:12
(Alliance News) - Abingdon Health PLC on Tuesday said it will start trading on the OTCQB Venture Market in the US next month.
The York, England-based maker of lateral flow diagnostic tests said by trading on the market, its shares will be available to trade in US dollars by investors during US working hours.
"Being available on the OTCQB platform has the potential to increase liquidity in Abingdon Health shares on AIM by attracting a larger universe of investors," the firm said.
Abingdon noted that the OTCQB is designed for entrepreneurial and development stage US and international companies.
Back in September, the company announced a second phase of a facility expansion at its Madison, Wisconsin site.
On Tuesday, Abingdon Health said its expansion in the US "will provide customers with unrivalled geographic optionality during a period of tariff and supply chain uncertainty".
Abingdon Health's shares will continue to trade on the London Stock Exchange's AIM market under the symbol ABDX. It will join the OTCQB market under the symbol ABDXF.
"Having seen our physical footprint and customer portfolio grow in the US following the establishment and expansion of our facility in Madison, Wisconsin, we believe that Abingdon Health is becoming increasingly relevant to US investors," said Executive Chair Chris Hand.
"This OTCQB launch will not only make our shares accessible to investors in the US - the largest lateral flow and med-tech market in the world with significant areas of unmet need - but also increase liquidity and benefit our investors on AIM."
Shares in Abingdon Health were up 3.6% at 7.51 pence on Tuesday afternoon in London.
By Michael Hennessey, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Abingdon Healt.